213 related articles for article (PubMed ID: 16309513)
1. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas.
Rajan N; Langtry JA
Clin Exp Dermatol; 2006 Jan; 31(1):140-1. PubMed ID: 16309513
[No Abstract] [Full Text] [Related]
2. Psoriasis induced by topical imiquimod.
Wu JK; Siller G; Strutton G
Australas J Dermatol; 2004 Feb; 45(1):47-50. PubMed ID: 14961909
[TBL] [Abstract][Full Text] [Related]
3. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod.
Fanti PA; Dika E; Vaccari S; Miscial C; Varotti C
Int J Dermatol; 2006 Dec; 45(12):1464-5. PubMed ID: 17184267
[No Abstract] [Full Text] [Related]
4. Localized pemphigus foliaceus induced by topical imiquimod treatment.
Lin R; Ladd DJ; Powell DJ; Way BV
Arch Dermatol; 2004 Jul; 140(7):889-90. PubMed ID: 15262711
[No Abstract] [Full Text] [Related]
5. Pemphigus-like lesions induced by imiquimod.
Bauza A; Del Pozo LJ; Saus C; Martin A
Clin Exp Dermatol; 2009 Jul; 34(5):e60-2. PubMed ID: 19438577
[TBL] [Abstract][Full Text] [Related]
6. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
Vun Y; Siller G
Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
[TBL] [Abstract][Full Text] [Related]
7. Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.
Drummond A; Pichler J; Argenziano G; Zalaudek I; Longo C; Lallas A; Piana S; Moscarella E
Australas J Dermatol; 2015 Nov; 56(4):e105-7. PubMed ID: 24575881
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
Sriprakash K; Godbolt A
Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
Sterry W; Ruzicka T; Herrera E; Takwale A; Bichel J; Andres K; Ding L; Thissen MR
Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
[TBL] [Abstract][Full Text] [Related]
10. Exaggerated imiquimod application site reactions in the context of systemic tumor necrosis factor-alpha inhibition: more than a coincidental occurrence?
Saggini A; Saraceno R; Chimenti S
Int J Immunopathol Pharmacol; 2011; 24(2):509-15. PubMed ID: 21658326
[TBL] [Abstract][Full Text] [Related]
11. Vasodilatory adverse events associated with topical imiquimod 5 percent cream.
Jacobs AA; Snavely N; Markus J; Rosen T
Dermatol Online J; 2008 Apr; 14(4):4. PubMed ID: 18627726
[TBL] [Abstract][Full Text] [Related]
12. [Imiquimod cream. A cream to use with precaution].
Taeron C
Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
[No Abstract] [Full Text] [Related]
13. Psoriasiform eruption and oral ulcerations as adverse effects of topical 5% imiquimod treatment in children: a report of four cases.
Smith WA; Siegel D; Lyon VB; Holland KE
Pediatr Dermatol; 2013; 30(6):e157-60. PubMed ID: 22612595
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod and pulmonary embolism: a case report.
Leroy B; Richez A; Wolf F; Descotes J; Vial T
Therapie; 2014; 69(2):180-1. PubMed ID: 24926639
[TBL] [Abstract][Full Text] [Related]
15. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
Neville JA; Williford PM; Jorizzo JL
J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma.
Sapijaszko MJ
Skin Therapy Lett; 2005; 10(6):2-5. PubMed ID: 16292452
[TBL] [Abstract][Full Text] [Related]
17. Arbor cutis: hyperkeratotic plaque secondary to the use of imiquimod for the treatment of squamous cell carcinoma in situ.
Knabel P; Cleaver L
Dermatol Surg; 2013 Apr; 39(4):655-7. PubMed ID: 23331869
[No Abstract] [Full Text] [Related]
18. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM
Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
20. Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod.
Jacob SE; Blyumin M
Dermatol Surg; 2008 Jun; 34(6):844-5. PubMed ID: 18363730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
